- Home
- NBIX vs OWL Comparison
NBIX vs OWL Comparison
Compare NBIX & OWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- OWL
- Stock Information
- Founded
- NBIX 1992
- OWL 2020
- Country
- NBIX United States
- OWL United States
- Employees
- NBIX N/A
- OWL N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- OWL Investment Managers
- Sector
- NBIX Health Care
- OWL Finance
- Exchange
- NBIX Nasdaq
- OWL Nasdaq
- Market Cap
- NBIX 13.2B
- OWL 11.6B
- IPO Year
- NBIX 1996
- OWL N/A
- Fundamental
- Price
- NBIX $128.91
- OWL $18.83
- Analyst Decision
- NBIX Strong Buy
- OWL Strong Buy
- Analyst Count
- NBIX 22
- OWL 14
- Target Price
- NBIX $165.59
- OWL $24.81
- AVG Volume (30 Days)
- NBIX 935.9K
- OWL 7.3M
- Earning Date
- NBIX 07-30-2025
- OWL 07-31-2025
- Dividend Yield
- NBIX N/A
- OWL 4.78%
- EPS Growth
- NBIX 2.97
- OWL 23.81
- EPS
- NBIX 3.39
- OWL 0.12
- Revenue
- NBIX $2,509,900,000.00
- OWL $2,618,831,000.00
- Revenue This Year
- NBIX $16.12
- OWL $18.76
- Revenue Next Year
- NBIX $15.06
- OWL $22.71
- P/E Ratio
- NBIX $38.04
- OWL $157.86
- Revenue Growth
- NBIX 18.42
- OWL 32.99
- 52 Week Low
- NBIX $84.23
- OWL $14.55
- 52 Week High
- NBIX $157.98
- OWL $26.73
- Technical
- Relative Strength Index (RSI)
- NBIX 46.34
- OWL 40.76
- Support Level
- NBIX $130.75
- OWL $19.58
- Resistance Level
- NBIX $137.44
- OWL $20.06
- Average True Range (ATR)
- NBIX 3.60
- OWL 0.70
- MACD
- NBIX -0.71
- OWL -0.14
- Stochastic Oscillator
- NBIX 33.88
- OWL 23.86
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About OWL Blue Owl Capital Inc.
Blue Owl Capital Inc is an alternative asset management firm. The company deploys private capital across Credit, GP Strategic Capital, and Real Estate platforms on behalf of institutional and private wealth clients. The company conducts its operations through Blue Owl Capital Holdings LP (Blue Owl Holdings) and Blue Owl Capital Carry LP (Blue Owl Carry). Its investor base includes a diversified mix of institutional investors, including public and private pension funds, endowments, foundations, family offices, private banks, high-net-worth individuals, asset managers, and insurance companies. The company generates substantially all of its revenues in the United States.